Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

PACS vs CCRN vs HCA vs THC vs CYH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PACS
PACS Group, Inc.

Financial - Conglomerates

Financial ServicesNYSE • US
Market Cap$5.27B
5Y Perf.+34.6%
CCRN
Cross Country Healthcare, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$423M
5Y Perf.-25.6%
HCA
HCA Healthcare, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$95.95B
5Y Perf.+38.5%
THC
Tenet Healthcare Corporation

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$17.01B
5Y Perf.+72.9%
CYH
Community Health Systems, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$408M
5Y Perf.-12.3%

PACS vs CCRN vs HCA vs THC vs CYH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PACS logoPACS
CCRN logoCCRN
HCA logoHCA
THC logoTHC
CYH logoCYH
IndustryFinancial - ConglomeratesMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care Facilities
Market Cap$5.27B$423M$95.95B$17.01B$408M
Revenue (TTM)$5.29B$761M$75.60B$21.45B$21.48B
Net Income (TTM)$192M$-99M$6.78B$1.70B$-88M
Gross Margin21.9%18.2%41.5%42.8%53.7%
Operating Margin5.9%-0.9%15.8%16.1%-39.8%
Forward P/E16.2x133.8x14.2x10.9x0.8x
Total Debt$3.20B$2M$50.20B$13.17B$11.58B
Cash & Equiv.$197M$109M$1.04B$2.88B$260M

PACS vs CCRN vs HCA vs THC vs CYHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PACS
CCRN
HCA
THC
CYH
StockApr 24May 26Return
PACS Group, Inc. (PACS)100134.6+34.6%
Cross Country Healt… (CCRN)10074.4-25.6%
HCA Healthcare, Inc. (HCA)100138.5+38.5%
Tenet Healthcare Co… (THC)100172.9+72.9%
Community Health Sy… (CYH)10087.7-12.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: PACS vs CCRN vs HCA vs THC vs CYH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HCA leads in 4 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. PACS Group, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. CYH also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
PACS
PACS Group, Inc.
The Banking Pick

PACS is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 29.3%, EPS growth 221.1%
  • 29.3% NII/revenue growth vs CCRN's -21.6%
  • +219.6% vs CYH's -11.7%
Best for: growth exposure
CCRN
Cross Country Healthcare, Inc.
The Defensive Pick

CCRN is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 0.78, Low D/E 0.7%, current ratio 3.78x
Best for: sleep-well-at-night
HCA
HCA Healthcare, Inc.
The Income Pick

HCA carries the broadest edge in this set and is the clearest fit for income & stability.

  • Dividend streak 5 yrs, beta 0.29, yield 0.7%
  • 9.0% margin vs CCRN's -13.0%
  • Beta 0.29 vs CYH's 1.60
  • 0.7% yield; 5-year raise streak; the other 4 pay no meaningful dividend
Best for: income & stability
THC
Tenet Healthcare Corporation
The Long-Run Compounder

THC is the clearest fit if your priority is long-term compounding and valuation efficiency.

  • 5.2% 10Y total return vs HCA's 450.5%
  • PEG 0.33 vs HCA's 0.67
  • Beta 0.71, current ratio 1.76x
Best for: long-term compounding and valuation efficiency
CYH
Community Health Systems, Inc.
The Value Play

CYH ranks third and is worth considering specifically for value.

  • Lower P/E (0.8x vs 14.2x)
Best for: value
See the full category breakdown
CategoryWinnerWhy
GrowthPACS logoPACS29.3% NII/revenue growth vs CCRN's -21.6%
ValueCYH logoCYHLower P/E (0.8x vs 14.2x)
Quality / MarginsHCA logoHCA9.0% margin vs CCRN's -13.0%
Stability / SafetyHCA logoHCABeta 0.29 vs CYH's 1.60
DividendsHCA logoHCA0.7% yield; 5-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)PACS logoPACS+219.6% vs CYH's -11.7%
Efficiency (ROA)HCA logoHCA11.3% ROA vs CCRN's -19.8%, ROIC 19.9% vs -0.9%

PACS vs CCRN vs HCA vs THC vs CYH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

PACSPACS Group, Inc.
FY 2024
Reportable Segment
100.0%$4.1B
CCRNCross Country Healthcare, Inc.
FY 2025
Other Services
100.0%$30M
HCAHCA Healthcare, Inc.
FY 2025
Managed Care And Other Insurers
50.5%$37.0B
Managed Medicare
18.4%$13.4B
Medicare
15.4%$11.3B
Medicaid
8.1%$5.9B
Managed Medicaid
5.0%$3.7B
International
2.5%$1.9B
THCTenet Healthcare Corporation
FY 2025
Ambulatory Care
50.2%$5.2B
Hospital Operations
49.8%$5.1B
CYHCommunity Health Systems, Inc.
FY 2025
Managed Care And Other Third Party Payors
58.4%$6.0B
Medicare
21.2%$2.2B
Medicaid
19.5%$2.0B
Self Pay Revenue
0.9%$96M

PACS vs CCRN vs HCA vs THC vs CYH — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLTHCLAGGINGCYH

Income & Cash Flow (Last 12 Months)

THC leads this category, winning 3 of 6 comparable metrics.

HCA is the larger business by revenue, generating $75.6B annually — 99.4x CCRN's $761M. HCA is the more profitable business, keeping 9.0% of every revenue dollar as net income compared to CCRN's -13.0%. On growth, CYH holds the edge at +2.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricPACS logoPACSPACS Group, Inc.CCRN logoCCRNCross Country Hea…HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
RevenueTrailing 12 months$5.3B$761M$75.6B$21.5B$21.5B
EBITDAEarnings before interest/tax$365M$9M$15.5B$4.3B-$7.8B
Net IncomeAfter-tax profit$192M-$99M$6.8B$1.7B-$88M
Free Cash FlowCash after capex$254M$41M$7.7B$3.3B-$200M
Gross MarginGross profit ÷ Revenue+21.9%+18.2%+41.5%+42.8%+53.7%
Operating MarginEBIT ÷ Revenue+5.9%-0.9%+15.8%+16.1%-39.8%
Net MarginNet income ÷ Revenue+3.6%-13.0%+9.0%+7.9%-0.4%
FCF MarginFCF ÷ Revenue+5.4%+10.2%+15.6%-0.9%
Rev. Growth (YoY)Latest quarter vs prior year-100.0%+6.7%+2.8%+2.8%
EPS Growth (YoY)Latest quarter vs prior year+75.0%-6.0%+44.6%+87.6%-45.2%
THC leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

THC leads this category, winning 3 of 7 comparable metrics.

At 0.8x trailing earnings, CYH trades at a 97% valuation discount to PACS's 27.6x P/E. Adjusting for growth (PEG ratio), THC offers better value at 0.38x vs HCA's 0.72x — a lower PEG means you pay less per unit of expected earnings growth.

MetricPACS logoPACSPACS Group, Inc.CCRN logoCCRNCross Country Hea…HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
Market CapShares × price$5.3B$423M$95.9B$17.0B$408M
Enterprise ValueMkt cap + debt − cash$8.3B$317M$145.1B$27.3B$11.7B
Trailing P/EPrice ÷ TTM EPS27.56x-4.47x15.12x12.53x0.77x
Forward P/EPrice ÷ next-FY EPS est.16.24x133.84x14.19x10.94x
PEG RatioP/E ÷ EPS growth rate0.72x0.38x
EV / EBITDAEnterprise value multiple22.63x23.75x9.37x6.34x
Price / SalesMarket cap ÷ Revenue1.00x0.40x1.27x0.80x0.03x
Price / BookPrice ÷ Book value/share5.53x1.31x1.97x
Price / FCFMarket cap ÷ FCF10.55x12.47x6.72x1.96x
THC leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

HCA leads this category, winning 5 of 9 comparable metrics.

PACS delivers a 20.1% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $-27 for CCRN. CCRN carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to PACS's 3.36x. On the Piotroski fundamental quality scale (0–9), HCA scores 7/9 vs CYH's 6/9, reflecting strong financial health.

MetricPACS logoPACSPACS Group, Inc.CCRN logoCCRNCross Country Hea…HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
ROE (TTM)Return on equity+20.1%-27.1%+19.6%
ROA (TTM)Return on assets+3.4%-19.8%+11.3%+5.7%-0.7%
ROICReturn on invested capital+5.6%-0.9%+19.9%+13.2%-70.1%
ROCEReturn on capital employed+7.0%-0.8%+27.0%+13.8%-87.3%
Piotroski ScoreFundamental quality 0–966776
Debt / EquityFinancial leverage3.36x0.01x1.47x
Net DebtTotal debt minus cash$3.0B-$106M$49.2B$10.3B$11.3B
Cash & Equiv.Liquid assets$197M$109M$1.0B$2.9B$260M
Total DebtShort + long-term debt$3.2B$2M$50.2B$13.2B$11.6B
Interest CoverageEBIT ÷ Interest expense-1.39x5.37x4.28x4.89x
HCA leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

THC leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in THC five years ago would be worth $29,044 today (with dividends reinvested), compared to $1,902 for CYH. Over the past 12 months, PACS leads with a +219.6% total return vs CYH's -11.7%. The 3-year compound annual growth rate (CAGR) favors THC at 40.7% vs CCRN's -17.7% — a key indicator of consistent wealth creation.

MetricPACS logoPACSPACS Group, Inc.CCRN logoCCRNCross Country Hea…HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
YTD ReturnYear-to-date-14.9%+62.4%-8.6%-2.7%-6.6%
1-Year ReturnPast 12 months+219.6%-5.4%+19.7%+27.4%-11.7%
3-Year ReturnCumulative with dividends+46.2%-44.3%+57.4%+178.5%-16.8%
5-Year ReturnCumulative with dividends+46.2%-22.5%+109.7%+190.4%-81.0%
10-Year ReturnCumulative with dividends+46.2%-10.5%+450.5%+523.4%-80.3%
CAGR (3Y)Annualised 3-year return+13.5%-17.7%+16.3%+40.7%-6.0%
THC leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CCRN and HCA each lead in 1 of 2 comparable metrics.

HCA is the less volatile stock with a 0.29 beta — it tends to amplify market swings less than CYH's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CCRN currently trades 87.3% from its 52-week high vs CYH's 64.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricPACS logoPACSPACS Group, Inc.CCRN logoCCRNCross Country Hea…HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
Beta (5Y)Sensitivity to S&P 5000.64x0.78x0.29x0.71x1.60x
52-Week HighHighest price in past year$43.08$14.99$556.52$247.21$4.47
52-Week LowLowest price in past year$7.50$7.43$330.00$146.60$2.38
% of 52W HighCurrent price vs 52-week peak+78.0%+87.3%+77.1%+78.5%+64.8%
RSI (14)Momentum oscillator 0–10048.953.130.852.946.4
Avg Volume (50D)Average daily shares traded772K552K1000K1.2M1.6M
Evenly matched — CCRN and HCA each lead in 1 of 2 comparable metrics.

Analyst Outlook

HCA leads this category, winning 1 of 1 comparable metric.

Analyst consensus: PACS as "Buy", CCRN as "Hold", HCA as "Buy", THC as "Buy", CYH as "Hold". Consensus price targets imply 38.1% upside for THC (target: $268) vs -18.9% for CCRN (target: $11). HCA is the only dividend payer here at 0.69% yield — a key consideration for income-focused portfolios.

MetricPACS logoPACSPACS Group, Inc.CCRN logoCCRNCross Country Hea…HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
Analyst RatingConsensus buy/hold/sellBuyHoldBuyBuyHold
Price TargetConsensus 12-month target$44.67$10.61$527.45$268.00$2.93
# AnalystsCovering analysts814463237
Dividend YieldAnnual dividend ÷ price+0.7%
Dividend StreakConsecutive years of raises01502
Dividend / ShareAnnual DPS$2.94
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.6%+10.5%+8.4%+0.5%
HCA leads this category, winning 1 of 1 comparable metric.
Key Takeaway

THC leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). HCA leads in 2 (Profitability & Efficiency, Analyst Outlook). 1 tied.

Best OverallTenet Healthcare Corporation (THC)Leads 3 of 6 categories
Loading custom metrics...

PACS vs CCRN vs HCA vs THC vs CYH: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is PACS or CCRN or HCA or THC or CYH a better buy right now?

For growth investors, PACS Group, Inc.

(PACS) is the stronger pick with 29. 3% revenue growth year-over-year, versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). Community Health Systems, Inc. (CYH) offers the better valuation at 0. 8x trailing P/E, making it the more compelling value choice. Analysts rate PACS Group, Inc. (PACS) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — PACS or CCRN or HCA or THC or CYH?

On trailing P/E, Community Health Systems, Inc.

(CYH) is the cheapest at 0. 8x versus PACS Group, Inc. at 27. 6x. On forward P/E, Tenet Healthcare Corporation is actually cheaper at 10. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Tenet Healthcare Corporation wins at 0. 33x versus HCA Healthcare, Inc. 's 0. 67x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — PACS or CCRN or HCA or THC or CYH?

Over the past 5 years, Tenet Healthcare Corporation (THC) delivered a total return of +190.

4%, compared to -81. 0% for Community Health Systems, Inc. (CYH). Over 10 years, the gap is even starker: THC returned +523. 4% versus CYH's -80. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — PACS or CCRN or HCA or THC or CYH?

By beta (market sensitivity over 5 years), HCA Healthcare, Inc.

(HCA) is the lower-risk stock at 0. 29β versus Community Health Systems, Inc. 's 1. 60β — meaning CYH is approximately 460% more volatile than HCA relative to the S&P 500. On balance sheet safety, Cross Country Healthcare, Inc. (CCRN) carries a lower debt/equity ratio of 1% versus 3% for PACS Group, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — PACS or CCRN or HCA or THC or CYH?

By revenue growth (latest reported year), PACS Group, Inc.

(PACS) is pulling ahead at 29. 3% versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). On earnings-per-share growth, the picture is similar: PACS Group, Inc. grew EPS 221. 1% year-over-year, compared to -565. 9% for Cross Country Healthcare, Inc.. Over a 3-year CAGR, HCA leads at 7. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — PACS or CCRN or HCA or THC or CYH?

HCA Healthcare, Inc.

(HCA) is the more profitable company, earning 9. 0% net margin versus -9. 0% for Cross Country Healthcare, Inc. — meaning it keeps 9. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: THC leads at 16. 1% versus -79. 4% for CYH. At the gross margin level — before operating expenses — THC leads at 82. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is PACS or CCRN or HCA or THC or CYH more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Tenet Healthcare Corporation (THC) is the more undervalued stock at a PEG of 0. 33x versus HCA Healthcare, Inc. 's 0. 67x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Tenet Healthcare Corporation (THC) trades at 10. 9x forward P/E versus 133. 8x for Cross Country Healthcare, Inc. — 122. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for THC: 38. 1% to $268. 00.

08

Which pays a better dividend — PACS or CCRN or HCA or THC or CYH?

In this comparison, HCA (0.

7% yield) pays a dividend. PACS, CCRN, THC, CYH do not pay a meaningful dividend and should not be held primarily for income.

09

Is PACS or CCRN or HCA or THC or CYH better for a retirement portfolio?

For long-horizon retirement investors, HCA Healthcare, Inc.

(HCA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 29), 0. 7% yield, +450. 5% 10Y return). Community Health Systems, Inc. (CYH) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HCA: +450. 5%, CYH: -80. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between PACS and CCRN and HCA and THC and CYH?

These companies operate in different sectors (PACS (Financial Services) and CCRN (Healthcare) and HCA (Healthcare) and THC (Healthcare) and CYH (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PACS is a small-cap high-growth stock; CCRN is a small-cap quality compounder stock; HCA is a mid-cap deep-value stock; THC is a mid-cap deep-value stock; CYH is a small-cap deep-value stock. HCA pays a dividend while PACS, CCRN, THC, CYH do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

PACS

High-Growth Disruptor

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Gross Margin > 13%
Run This Screen
Stocks Like

CCRN

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

HCA

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

THC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

CYH

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 142%
  • Gross Margin > 32%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform PACS and CCRN and HCA and THC and CYH on the metrics below

Revenue Growth>
%
(PACS: 29.3% · CCRN: -100.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.